Cour Pharmaceuticals Development
Tim Walbert is an experienced professional in the biotechnology and pharmaceutical sectors, currently serving as a Senior Advisor at Amgen. Walbert holds multiple board memberships at Cour Pharmaceuticals Development Co., Inc., Sagimet Biosciences, Mirum Pharmaceuticals, and Century Therapeutics. An alumnus of Muhlenberg College, Walbert earned a Bachelor of Arts in Business between 1985 and 1989, and completed secondary education at Catasauqua High School from 1981 to 1985.
This person is not in the org chart
Cour Pharmaceuticals Development
Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.